Flow cytometric DNA analysis with cytokeratin gating of formalin-fixed deparaffinized breast cancer nuclei

American Journal of Clinical Pathology

Volumn 110, Issue 2, 1998, Pages 227-237

  McCormick, Stanley R ^a   Peters, Avis A ^a   Schrauth, John B ^a  

^a United Hospital   (United States)

Author keywords

Breast carcinoma; Cytokeratin; DNA; Heteroploid; Multiparameter flow cytometry; Paraffin embedded tissue; S phase fraction

Indexed keywords

CYTOKERATIN; DNA; FORMALDEHYDE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY CAM 5.2; MONOCLONAL ANTIBODY CK 14; MONOCLONAL ANTIBODY CK 18; MONOCLONAL ANTIBODY CK 8; MONOCLONAL ANTIBODY KL 1; MONOCLONAL ANTIBODY MAK 6; PARAFFIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST BIOPSY; BREAST CANCER; CELL CYCLE S PHASE; CELL LABELING; DNA CONTENT; DNA DETERMINATION; FLOW CYTOMETRY; HISTOGRAM; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PLOIDY; PRIORITY JOURNAL; STAINING;

EID: 0031823538     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/110.2.227     Document Type: Article

References (18)

1. Hedley DW, Clark GM, Cornelisse CJ, et al. Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry. 1993;14:482-485.
2. Clark GM, Dressler LG, Owens MA, et al. Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med. 1989;320:627-633.
3. O'Reilly SM, Camplejohn RS, Barnes DM, et al. Node-negative breast cancer: prognostic subgroups defined by tumor size and flow cytometry. J Clin Oncol. 1990;8:2040-2046.
4. Sigurdsson H, Baldetorp B, Borg A, et al. Indicators of prognosis in node-negative breast cancer. N Engl J Med. 1990;1045-1053.
5. Wingren S, Stal O, Sullivan S, et al. S-phase fraction after gating on epithelial cells predicts recurrence in node-negative breast cancer. Int J Cancer. 1994;59:7-10.
6. Clark GM, Mathieu MC, Owens MA, et al. Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. J Clin Oncol. 1992;10:428-432.
7. Stal O, Dufmats M, Hatschek T, et al. S-phase fraction is a prognostic factor in stage I breast carcinoma. J Clin Oncol. 1993;9:1717-1722.
8. Stal O, Skoog L, Rutqvist LE, et al. SPF predicts response to adjuvant chemotherapy. Br J Cancer. 1994;70:1258-1262.
9. Hedley DW, Friedlander ML, Taylor IW, et al. Method for analysis of cellular DNA content of paraffin-embedded pathological material using flow cytometry. J Histochem Cytochem. 1983;31:1333-1335.
10. Visscher DW, VanBree G, Ottosen S, et al. Flow cytometric enumeration and kinetic analysis of inflammatory cell populations in breast carcinomas. Anal Cell Pathol. 1993;5:321-330.
11. Shankey TV, Rabinovitch PS, Bagwell B, et al. Guidelines for implementation of clinical DNA cytometry. Cytometry. 1993;14:472-477.
12. O'Brien MC, Gupta RK, Lee SY, et al. Use of a multiparametric panel to target subpopulations in a heterogeneous solid tumor model for improved analytical accuracy. Cytometry. 1995;21:76-83.
13. Kimmig R, Speisberg H, Kapsner T, et al. Flow cytometric DNA analysis of breast cancer by two colour method using cytokeratin labeling for identification of tumour cells. Anal Cell Pathol. 1994;7:205-215.
14. Wingren S, Stal O, Nordenskjold B. Flow cytometric analysis of S-phase fraction in breast carcinomas using gating on cells containing cytokeratin. Br J Cancer. 1994;69:546-549.
15. Frei JV, Rizkalla K, Martinez VJ. Proliferative cell indices measured by DNA flow cytometry in node-negative adenocarcinomas of breast: accuracy and significance in cytokeratin-stained archival specimens. Mod Pathol. 1994;9:925-929.
16. Ferrero M, Spyratos F, LeDoussal V, et al. Flow cytometric analysis of DNA content and keratins by using CK7, CK8, CK18, CK19, and KL1 monoclonal antibodies in benign and malignant human breast tumors. Cytometry. 1990;11:716-724.
17. Zarbo RJ, Visscher DW, Crissman JD. Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen. Anal Quant Cytol Histol. 1989;11:392-402.
18. Brown RD, Linden MD, Mackowiak P, et al. The effect of number of histogram events on reproducibility and variation of flow cytometric proliferation measurement. Am J Clin Pathol. 1996;105:696-704.